Incyte
INCY
#1110
Rank
C$27.80 B
Marketcap
C$141.63
Share price
2.05%
Change (1 day)
34.82%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of September 2025 : C$4.04 Billion

According to Incyte's latest financial reports the company has C$4.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$3.09 B-36.14%
2023-12-31C$4.84 B10.33%
2022-12-31C$4.39 B46.86%
2021-12-31C$2.99 B30.29%
2020-12-31C$2.29 B-16.95%
2019-12-31C$2.76 B41.16%
2018-12-31C$1.95 B33.24%
2017-12-31C$1.47 B35.34%
2016-12-31C$1.08 B10.67%
2015-12-31C$0.98 B40.95%
2014-12-31C$0.69 B28.56%
2013-12-31C$0.54 B138.55%
2012-12-31C$0.22 B-19.56%
2011-12-31C$0.28 B-33.4%
2010-12-31C$0.42 B-14.34%
2009-12-31C$0.49 B105.57%
2008-12-31C$0.24 B-5.88%
2007-12-31C$0.25 B-31.03%
2006-12-31C$0.37 B-7.65%
2005-12-31C$0.40 B-28.82%
2004-12-31C$0.56 B48.04%
2003-12-31C$0.38 B-43.75%
2002-12-31C$0.67 B-16.26%
2001-12-31C$0.80 B-7.24%
2000-12-31C$0.87 B803.96%
1999-12-31C$96.48 M-43.56%
1998-12-31C$0.17 B115.22%
1997-12-31C$79.44 M663.15%
1996-12-31C$10.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
C$13.04 B 222.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.93 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$13.69 B 238.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.70 B 411.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.52 B-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.33 B-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$13.47 B 232.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
C$0.10 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$81.52 M-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA